Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BMDMSC for Azoospermia
NCT02025270Phase 2Completed
- Sponsor
- Al-Azhar University
- Start
- Oct 2012
- Primary completion
- Oct 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in nonobstructive azoospermia (NOA), sponsored by Al-Azhar University. Primary endpoint: All Cases Improvement at 1 year. Started Oct 2012; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
nonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on NCT02025270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025270.